Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 5% | 8.2% | 15.1% |
| Success rate | 100% | 68% | 82% |
| Transactions |
4
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| President, Chief Executive Officer, Director | Zimmer Biomet Holdings Inc | Dec. 19, 2017 - |
| Executive Vice President, Group President - Minimally Invasive Therapies Group | Medtronic PLC | Jan. 1, 2015 - Dec. 18, 2017 |
Search